PR85342

PLYMOUTH MEETING, Pennsylvania, Sept. 3, 2020 /PRNewswire=KYODO JBN/ --

--Gold standard clinical practice guidelines in oncology updated and translated

for greater global accessibility; free online at NCCN.org/global

(https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=4122105156&u=http%3A%2F%2Fwww.nccn.org%2Fglobal&a=NCCN.org%2Fglobal ).

The National Comprehensive Cancer Network(R) (NCCN (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1384938308&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN )(R))

today announced the availability of both new and updated Chinese language

versions of NCCN Guidelines (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2018806004&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines )(R) for numerous high-incidence cancer types. These treatment recommendations

can be accessed for free at NCCN.org/global (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2567988005&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Finternational_adaptations.aspx%23chinese_translations&a=NCCN.org%2Fglobal ) or via the Virtual Library of NCCN

Guidelines(R) App (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=3289578312&u=https%3A%2F%2Fwww.nccn.org%2Fapps%2F&a=App ).

Photo - https://mma.prnewswire.com/media/1246652/Newswire_Translation_Chinese.jpg 

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg 

NCCN is devoted to defining and advancing high-quality, high-value,

patient-centered cancer care globally. NCCN Guidelines are the recognized

standard for clinical direction and policy in cancer management and the most

thorough and frequently-updated clinical practice guidelines available in any

area of medicine. They are written by subject-specific, multidisciplinary

panels of experts from across 30 leading cancer centers (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2845993403&u=https%3A%2F%2Fwww.nccn.org%2Fmembers%2Fnetwork.aspx&a=30+leading+cancer+centers ) in the United States. There are currently 24 global adaptations and

230 translations of NCCN resources across 47 different languages.  

"Publishing NCCN Guidelines in multiple languages helps us ensure people

everywhere can have access to the best cancer care at the right time," said

Robert W. Carlson, MD, Chief Executive Officer, NCCN. "Cancer treatment methods

are becoming more sophisticated and complicated every day, thanks to emerging

research. These new and updated Chinese-language guidelines enhance

understanding for primarily Chinese-fluent oncology providers in Asia and

throughout the world, and allow them to readily stay up-to-date on the latest

evidence-based and expert consensus recommendations."

China is home to the largest number of downloads for NCCN Guidelines outside

the United States, with more than 200,000 downloads in 2019 alone. The country

also boasts the highest number of non-U.S. verified users for NCCN.org with

more than 42,000. South Korea, Japan, and Thailand are also among the

most-represented countries to download NCCN Guidelines.

Chinese-language NCCN Guidelines currently cover the following topics:

    --  Acute Myeloid Leukemia (AML)

    --  Breast Cancer

    --  Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

    --  Colon Cancer

    --  Gastric Cancer

    --  Hairy Cell Leukemia

    --  Head and Neck Cancers

    --  Hodgkin Lymphoma

    --  Melanoma (Cutaneous)

    --  Multiple Myeloma          

    --  Non-small Cell Lung Cancer                  

    --  Primary Cutaneous Lymphomas

    --  T-Cell Lymphomas

In addition to these treatment recommendations for adults with cancer, NCCN has

also recently announced the translation of NCCN Guidelines for Pediatric Acute

Lymphoblastic Leukemia (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2236581085&u=https%3A%2F%2Fwww.nccn.org%2Fabout%2Fnews%2Fnewsinfo.aspx%3FNewsID%3D2170&a=NCCN+Guidelines+for+Pediatric+Acute+Lymphoblastic+Leukemia )

into Japanese and Chinese. The NCCN Distress Thermometer (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=493602904&u=https%3A%2F%2Fwww.nccn.org%2Fabout%2Fnews%2Fnewsinfo.aspx%3FNewsID%3D2197&a=NCCN+Distress+Thermometer )--a tool for gauging and treating

the psycho-social wellbeing in people with cancer--has also been translated into

46 languages, including Chinese, Japanese, Korean, Malay, Thai, and many more.

Visit NCCN.org/global/international_adaptations.aspx (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2831152057&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Finternational_adaptations.aspx&a=NCCN.org%2Fglobal%2Finternational_adaptations.aspx ) to view and download

these free resources.

The NCCN global team also offers patient-friendly versions

(https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=331429008&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx&a=patient-friendly+versions ) in several languages, including Chinese, Japanese, and Korean.

NCCN also provides NCCN Framework for Resource Stratification of NCCN Guidelines

(NCCN Framework (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2304155871&u=https%3A%2F%2Fwww.nccn.org%2Fframework%2Fdefault.aspx&a=NCCN+Framework )(TM)) and NCCN Harmonized Guidelines (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1544397293&u=https%3A%2F%2Fwww.nccn.org%2Fharmonized%2Fdefault.aspx&a=NCCN+Harmonized+Guidelines )(TM) that merge optimal recommendations and

pragmatic considerations for treatment in resource-constrained settings,

such as low- and middle-income countries.

Learn more at NCCN.org/global (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=4122105156&u=http%3A%2F%2Fwww.nccn.org%2Fglobal&a=NCCN.org%2Fglobal )

and join the conversation online with the hashtag #NCCNGlobal

(https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1575202354&u=https%3A%2F%2Ftwitter.com%2Fsearch%3Fq%3D%2523NCCNGlobal%26src%3Dtyped_query%26f%3Dlive&a=%23NCCNGlobal ).

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network(R) (NCCN (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1384938308&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN )(R))

is a not-for-profit alliance of leading cancer centers (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=3561663656&u=https%3A%2F%2Fwww.nccn.org%2Fmembers%2Fnetwork.aspx&a=leading+cancer+centers ) devoted to patient care, research, and education. NCCN is dedicated to

improving and facilitating quality, effective, efficient, and accessible cancer

care so patients can live better lives. The NCCN Clinical Practice Guidelines

in Oncology (NCCN Guidelines (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2018806004&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines )(R)) provide transparent, evidence-based, expert consensus recommendations for

cancer treatment, prevention, and supportive services; they are the recognized

standard for clinical direction and policy in cancer management and the most

thorough and frequently-updated clinical practice guidelines available in any

area of medicine. The NCCN Guidelines for Patients (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=4167515442&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx&a=NCCN+Guidelines+for+Patients )(R) provide expert cancer treatment information

to inform and empower patients and caregivers, through support from the NCCN

Foundation (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=3863313845&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fwaystogive%2Fdefault.aspx&a=NCCN+Foundation )(R). NCCN also advances continuing education (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1236192253&u=https%3A%2F%2Feducation.nccn.org%2F&a=continuing+education ),

global initiatives (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1803589528&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Fdefault.aspx&a=global+initiatives ),

policy (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2252485275&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fmeetings%2Foncology_policy_program%2Fdefault.aspx&a=policy ), and research collaboration (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=4243747182&u=https%3A%2F%2Fwww.nccn.org%2Fclinical_trials%2Fclinicians.aspx&a=collaboration ) and publication (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1030936893&u=https%3A%2F%2Fwww.nccn.org%2Fjnccn%2F&a=publication ) in oncology.

Visit https://NCCN.org for more information and follow NCCN on

Facebook @NCCNorg (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=1969997776&u=http%3A%2F%2Fwww.facebook.com%2FNCCNorg&a=%40NCCNorg ),

Instagram @NCCNorg (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=3583220740&u=https%3A%2F%2Fwww.instagram.com%2Fnccnorg%2F&a=%40NCCNorg ),

and Twitter @NCCN (https://c212.net/c/link/?t=0&l=en&o=2904206-1&h=2849885746&u=http%3A%2F%2Fwww.twitter.com%2Fnccn&a=%40NCCN ).

Media Contact:

Rachel Darwin

267-622-6624

darwin@nccn.org

SOURCE: National Comprehensive Cancer Network